Search results for "Bioinformatics"

showing 10 items of 1632 documents

Direct antiviral agents and risk of HCC: Waiting for Godot.

2018

Carcinoma HepatocellularHepatologyWaiting Listsbusiness.industryLiver NeoplasmsBioinformatics01 natural sciencesAntiviral AgentsHepatitis C010104 statistics & probability03 medical and health sciences0302 clinical medicineText miningMedicineHumans030211 gastroenterology & hepatology0101 mathematicsbusinessJournal of hepatology
researchProduct

Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies.

2011

Despite great progress in diagnosis and management of hepatocellular carcinoma (HCC), the exact biology of the tumor remains poorly understood overall limiting the patients' outcome. Detailed analysis and characterization of the molecular mechanisms and subsequently individual prediction of corresponding prognostic traits would revolutionize both diagnosis and treatment of HCC and is the key goal of modern personalized medicine. Over the recent years systematic approaches for the analysis of whole tumor genomes and transcriptomes as well as epigenomes became affordable tools in translational research. This includes simultaneous analyses of thousands of molecular targets using microarray-bas…

Carcinoma HepatocellularSystems biologyGenomicsTranslational researchDiseaseBioinformaticsTarget therapyEpigenesis GeneticTranslational Research BiomedicalCancer stem cellmedicineHumansMolecular pathogenesisPathology MolecularHepatologybusiness.industrySystems BiologyLiver NeoplasmsGenomicsGene expression profilemedicine.diseaseHepatocellular carcinomaNeoplastic Stem CellsPersonalized medicineLiver cancerbusinessTranscriptomeLiver cancerSignal TransductionJournal of hepatology
researchProduct

Neuroinflammatory mechanisms in ischemic stroke: Focus on cardioembolic stroke, background, and therapeutic approaches

2020

One of the most important causes of neurological morbidity and mortality in the world is ischemic stroke. It can be a result of multiple events such as embolism with a cardiac origin, occlusion of small vessels in the brain, and atherosclerosis affecting the cerebral circulation. Increasing evidence shows the intricate function played by the immune system in the pathophysiological variations that take place after cerebral ischemic injury. Following the ischemic cerebral harm, we can observe consequent neuroinflammation that causes additional damage provoking the death of the cells; on the other hand, it also plays a beneficial role in stimulating remedial action. Immune mediators are the or…

Cardiac embolismNeuroimmunomodulationIschemiaInflammationReview030204 cardiovascular system & hematologyBioinformaticsCatalysisProinflammatory cytokineBrain IschemiaInorganic Chemistrylcsh:Chemistry03 medical and health sciencesCerebral circulation0302 clinical medicineImmune systemNeuroinflammationmedicineAnimalsHumansPhysical and Theoretical ChemistryMolecular Biologylcsh:QH301-705.5SpectroscopyNeuroinflammationInflammationEmbolic StrokeIschemic strokebusiness.industryOrganic ChemistryBrainGeneral Medicinemedicine.diseasePathophysiologyComputer Science ApplicationsStrokeEmbolismlcsh:Biology (General)lcsh:QD1-999Cytokinesmedicine.symptombusiness030217 neurology & neurosurgery
researchProduct

Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardioto…

2015

Although treatment for heart failure induced by cancer therapy has improved in recent years, the prevalence of cardiomyopathy due to antineoplastic therapy remains significant worldwide. In addition to traditional mediators of myocardial damage, such as reactive oxygen species, new pathways and target cells should be considered responsible for the impairment of cardiac function during anticancer treatment. Accordingly, there is a need to develop novel therapeutic strategies to protect the heart from pharmacologic injury, and improve clinical outcomes in cancer patients. The development of novel protective therapies requires testing putative therapeutic strategies in appropriate animal model…

Cardiac function curveACE inhibitorsCardiotonic AgentsNeuregulin-1CardiomyopathyAntineoplastic AgentsPreclinical modelsCardioprotectionCardiotonic AgentsPharmacologyBioinformaticsmedicine.disease_causeCancer therapy-induced cardiac injury ;Preclinical modelsMitochondria HeartBeta-blockersNeoplasmsCancer therapy-induced cardiac injuryMedicineAnimalsHumansCardiac stem cellsCardioprotectionCardiotoxicityACE inhibitors; Beta-blockers; Cancer therapy-induced cardiac injury; Cardiac stem cells; Cardioprotection; Mitochondria; Neuregulin-1; Oxidative stress; Preclinical models; Statinsbusiness.industryStatinsCancermedicine.diseaseCardiotoxicityMitochondriaCancer therapy-induced cardiac injury Preclinical models Cardioprotection Mitochondria Neuregulin-1 Oxidative stress Statins Beta-blockers ACE inhibitors Cardiac stem cellsDisease Models AnimalOxidative StressHeart failureCardiology and Cardiovascular MedicinebusinessOxidative stress
researchProduct

Chemotherapy cardiotoxicity: cardioprotective drugs and early identification of cardiac dysfunction.

2016

Background: Chemotherapy cardiotoxicity is an emerging problem and it is very important to prevent cardiac dysfunction caused by anticancer drugs. The aim of this study was to assess the alterations of the cardiac function induced by chemotherapy in a follow-up of 2 years and to evaluate the cardioprotective role of angiotensin-converting enzyme inhibitors (ACEIs) in the prevention of cardiac dysfunction. Methods: A prospective study was carried out using patients with breast cancer (85 women; median age 57W12years) and other inclusion and exclusion criteria. On the basis of treatment, patients were divided into six groups: fluorouracil-epirubicincyclophosphamide, FEC (group A); FEC and tra…

Cardiac function curveAdultmedicine.medical_specialtyCardiotonic Agentsmedicine.medical_treatmentAngiotensin-Converting Enzyme InhibitorsBreast Neoplasms030204 cardiovascular system & hematologyBioinformaticsCardiac dysfunctionAngiotensin-converting enzyme inhibitor; Cardiotoxicity; Chemotherapy; Prevention; Tissue Doppler imaging; Adult; Aged; Aged 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiotonic Agents; Cardiotoxicity; Early Diagnosis; Echocardiography Doppler; Female; Follow-Up Studies; Humans; Middle Aged; Prospective Studies03 medical and health sciencesTissue Doppler imaging0302 clinical medicinecardiac toxicity anti cancer drugs cardiac dysfunctionInternal medicineAntineoplastic Combined Chemotherapy Protocols80 and overMedicineChemotherapyHumansProspective StudiesAgedAged 80 and overCardiotoxicityChemotherapybusiness.industryPreventionFollow up studiesDopplerGeneral MedicineMiddle AgedCardiotoxicityEchocardiography DopplerClinical trialEarly DiagnosisAngiotensin-converting enzyme inhibitorEchocardiography030220 oncology & carcinogenesiscardiovascular systemCardiologyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesJournal of cardiovascular medicine (Hagerstown, Md.)
researchProduct

Cardioprotective effects of phytopigments via multiple signaling pathways.

2021

Abstract Background Cardiovascular diseases (CVDs) are among the deadliest non-communicable diseases, and millions of dollars are spent every year to combat CVDs. Unfortunately, the multifactorial etiology of CVDs complicates the development of efficient therapeutics. Interestingly, phytopigments show significant pleiotropic cardioprotective effects both in vitro and in vivo. Purpose This review gives an overview of the cardioprotective effects of phytopigments based on in vitro and in vivo studies as well as clinical trials. Methods A literature-based survey was performed to collect the available data on cardioprotective activities of phytopigments via electronic search engines such as Pub…

Cardiotonic AgentsPharmaceutical ScienceAnthraquinonesXanthophyllsBioinformaticsstatAntioxidantsAnthocyaninsDrug DiscoveryMedicineAnimalsHumansClinical efficacyProtein kinase BPharmacologyFlavonoidsbusiness.industryNF-kappa BAMPKCarotenoidsClinical trialComplementary and alternative medicineCardiotoxicitiesCardiac hypertrophyMolecular MedicineSignal transductionbusinessSignal TransductionPhytomedicine : international journal of phytotherapy and phytopharmacology
researchProduct

Identification and characterisation of the dopamine receptor II from the cat flea Ctenocephalides felis (CfDopRII)

2006

International audience; G protein-coupled receptors (GPCRs) represent a protein family with a wide range of functions. Approximately 30% of human drug targets are GPCRs, illustrating their pharmaceutical relevance. In contrast, the knowledge about invertebrate GPCRs is limited and is mainly restricted to model organisms like Drosophila melanogaster and Caenorhabditis elegans. Especially in ectoparasites like ticks and fleas, only few GPCRs are characterised. From the cat flea Ctenocephalides felis, a relevant parasite of cats and dogs, no GPCRs are known so far. Thus, we performed a bioinformatic analysis of available insect GPCR sequences from the honeybee Apis mellifera, the mosquito Anop…

Cat fleaAnopheles gambiaeMolecular Sequence Dataved/biology.organism_classification_rank.speciesBiochemistryCell LineReceptors DopamineAnimals Genetically ModifiedXenopus laevisAnimalsHumansAmino Acid SequenceCloning MolecularModel organismMolecular BiologyPhylogenyCaenorhabditis elegansCtenocephalides[INFO.INFO-BI] Computer Science [cs]/Bioinformatics [q-bio.QM]G protein-coupled receptorGeneticsbiologyved/biologyEcologyFelisComputational Biologybiology.organism_classificationDrosophila melanogasterMultigene FamilyInsect ScienceOocytesInsect ProteinsSiphonapteraFemaleRNA Interference[INFO.INFO-BI]Computer Science [cs]/Bioinformatics [q-bio.QM]Drosophila melanogasterSequence Alignment[CHIM.CHEM]Chemical Sciences/Cheminformaticshormones hormone substitutes and hormone antagonistsInsect Biochemistry and Molecular Biology
researchProduct

Cytotoxicity, anti-angiogenic, apoptotic effects and transcript profiling of a naturally occurring naphthyl butenone, guieranone A

2012

Abstract Background Malignant diseases are responsible of approximately 13% of all deaths each year in the world. Natural products represent a valuable source for the development of novel anticancer drugs. The present study was aimed at evaluating the cytotoxicity of a naphtyl butanone isolated from the leaves of Guiera senegalensis, guieranone A (GA). Results The results indicated that GA was active on 91.67% of the 12 tested cancer cell lines, the IC50 values below 4 μg/ml being recorded on 83.33% of them. In addition, the IC50 values obtained on human lymphoblastic leukemia CCRF-CEM (0.73 μg/ml) and its resistant subline CEM/ADR5000 (1.01 μg/ml) and on lung adenocarcinoma A549 (0.72 μg/m…

Cell cycle checkpointCytotoxicityApoptosisMicroarrayBiologyBioinformaticslcsh:RC254-282BiochemistryAngiogensismedicineCytotoxic T cellDoxorubicinlcsh:QH573-671CytotoxicityMolecular Biologylcsh:CytologyResearchCell BiologyCell cyclelcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensMolecular biologyChorioallantoic membraneCell cultureApoptosisGuieranone APharmacogenomicsmedicine.drugCell Division
researchProduct

Risk Factors and Molecular Features Associated with Bladder Cancer Development

2017

Bladder cancer remains a global epidemiologic problem, with a strong male predominance and association with tobacco smoking. However, several other risk factors have also been associated with development of this disease, which is characterized by alterations in multiple molecular pathways. Development of the more prevalent, less aggressive, recurrent, noninvasive tumors is characterized by constitutive activation of the Ras–MAPK pathway. The less common but more aggressive invasive tumors, which have a higher mortality rate, are characterized by alterations in the p53 and retinoblastoma pathways. Alterations in pathways involved in cell-cycle regulation, apoptosis, cell signaling, angiogene…

Cell signalingBladder cancerRetinoblastomabusiness.industryAngiogenesisMortality rate030232 urology & nephrologyDiseaseCell cyclemedicine.diseaseBioinformatics03 medical and health sciences0302 clinical medicineApoptosis030220 oncology & carcinogenesismedicinebusiness
researchProduct

Molecular evolution of the metazoan extracellular matrix: cloning and expression of structural proteins from the demosponges Suberites domuncula and …

2000

One crucial event during evolution to multicellularity was the development of either direct cell–cell contact or indirect interaction via extracellular matrix (ECM) molecules. The identification of those polypeptides provides conclusive data on the phylogenetic relationship of metazoan phyla and helps us to understand the position of the Metazoa among the other kingdoms. Recently it became evident that the ECM of sponges is amazingly complex; it is composed of fibrous molecules, e.g., collagen, and their corresponding receptors, which are highly similar to those existing in other metazoan phyla. While these data already support the view of monophyly of Metazoa, additional studies are requir…

Cell signalingDNA ComplementaryDermatopontinMolecular Sequence DataGene ExpressionBiologyBioinformaticsTransplantation AutologousExtracellular matrixEvolution MolecularMyotrophinGeneticsAnimalsAmino Acid SequenceCloning MoleculareducationGrowth SubstancesMolecular BiologyPeptide sequenceEcology Evolution Behavior and SystematicsPhylogenyCell Aggregationeducation.field_of_studyExtracellular Matrix ProteinsBase SequenceSequence Homology Amino AcidReceptor Protein-Tyrosine Kinasesbiology.organism_classificationRecombinant ProteinsCell biologyPoriferaSuberites domunculaTransplantationChondroitin Sulfate ProteoglycansIntercellular Signaling Peptides and ProteinsCollagenCarrier ProteinsCell Adhesion MoleculesFunction (biology)Journal of molecular evolution
researchProduct